Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer

被引：0
|
作者：
Takashi Mizowaki
Yoshiki Norihisa
Kenji Takayama
Itaru Ikeda
Haruo Inokuchi
Kiyonao Nakamura
Tomomi Kamba
Takahiro Inoue
Toshiyuki Kamoto
Osamu Ogawa
Masahiro Hiraoka
机构：
[1] Kyoto University,Department of Radiation Oncology and Image
[2] Kyoto University,applied Therapy, Graduate School of Medicine
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Localized prostate cancer; Neoadjuvant hormonal therapy; Intensity-modulated radiation therapy; Prostate-specific antigen failure-free survival; Overall survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：783 / 790
页数：7
相关论文
共 50 条
  • [31] Benefit of adjuvant chemotherapy in patients with high-risk UICC II colon cancer T4N0M0: A ten-year population based analysis of 3544 cases.
    Teufel, Andreas
    Furst, Alois
    Gerken, Michael
    Hohenthanner, Ina
    Klinkhammer-Schalke, Monika
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [32] Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer
    D'Amico, AV
    Saegaert, T
    Chen, MH
    Renshaw, AA
    George, D
    Oh, W
    Kantoff, PW
    CANCER, 2002, 95 (02) : 275 - 280
  • [33] Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer
    Ekici, Kemal
    Pepele, Eda K.
    Yaprak, Bahaddin
    Ternelli, Oztun
    Eraslan, Aysun F.
    Kucuk, Nadir
    Altinok, Ayse Y.
    Sut, Pelin A.
    Alpak, Ozlem D.
    Colak, Cemil
    Mayadagli, Alpaslan
    Medical Dosimetry, 2016, 41 (04) : 329 - 333
  • [34] Biological dose summation of intensity-modulated arc therapy and image-guided high-dose-rate interstitial brachytherapy in intermediate- and high-risk prostate cancer
    Frohlich, Georgina
    Agoston, Peter
    Jorgo, Kliton
    Polgar, Csaba
    Major, Tibor
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (03) : 260 - 266
  • [35] Risk-Adapted Postmastectomy Radiation Therapy for Patients with Clinical T1-2N0-1 Breast Cancer after Neoadjuvant Chemotherapy
    Wang, X.
    Yin, Z.
    Xu, L.
    Wang, Q.
    Zhao, L.
    Yuan, Z.
    Wang, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E595 - E596
  • [36] A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy
    Caumont, Fernando
    Conti, Galen
    Hurwitz, Lauren M.
    Kuo, Claire
    Levie, Katherine E.
    Badiozamani, Kasra
    Frankel, Jason K.
    Flores, John Paul
    Brand, Timothy C.
    Chaurasia, Avinash
    Rosner, Inger L.
    Stroup, Sean P.
    Musser, John E.
    Cullen, Jennifer
    Porter, Christopher R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (10) : 794.e1 - 794.e9
  • [37] Long-term outcome of IMRT with neoadjuvant hormonal therapy under early salvage policy for T3-4N0M0 prostate cancer
    Mizowaki, T.
    Takayama, K.
    Norihisa, Y.
    Ikeda, I.
    Kamba, T.
    Kamoto, T.
    Inoue, T.
    Nakamura, E.
    Ogawa, O.
    Hiraoka, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S91 - S91
  • [38] Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
    Alina M. Mateo
    Todd A. Pezzi
    Mark Sundermeyer
    Cynthia A. Kelley
    V. Suzanne Klimberg
    Christopher M. Pezzi
    Annals of Surgical Oncology, 2017, 24 : 1050 - 1056
  • [39] Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
    Mateo, Alina M.
    Pezzi, Todd A.
    Sundermeyer, Mark
    Kelley, Cynthia A.
    Klimberg, V. Suzanne
    Pezzi, Christopher M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 1050 - 1056
  • [40] High Dose Localized Irradiation to Intermediate and High Risk Prostate Cancer with Gold Fiducial Marker based Intensity Modulated Radiotherapy Combined with Neoadjuvant and Concurrent Hormonal Therapy
    Hatano, K.
    Imagunbai, T.
    Sakai, M.
    Araki, H.
    Tohyama, N.
    Kodama, T.
    Kojima, T.
    Kawachi, T.
    Ueda, K.
    Maruoka, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S340 - S340
12345